Impact factor jama oncol
WitrynaAnnals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review … WitrynaThis study aims to show that split-course therapy may achieve good local control tumor response rates at 6 months for those patients who are unfit to tolerate continuous therapy, and may be better tolerated, with decreased side effects. 103 Appropriate patient selection is critical, given that split-course therapy carries the potential risk of ...
Impact factor jama oncol
Did you know?
Witryna1 lip 2024 · The impact factor is calculated by dividing the number of times the articles are cited in the last two years by the total number of publications in those two years. … Witryna5 lip 2024 · Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review. ... JAMA Oncol. 2024;5(10):e191870. doi: ... Early impact of COVID-19 on the conduct of oncology clinical trials and long-term opportunities for transformation: findings from an American Society of Clinical Oncology Survey.
Witryna1 lis 2024 · Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: A Phase 2 Randomized Clinical Trial ... JAMA Oncol. 2024 Nov 1;5(11):e192553. doi: 10.1001/jamaoncol.2024.2553. Epub 2024 Nov 14. Witryna14 kwi 2024 · 《Journal of Thoracic Oncology》发布于爱科学网，并永久归类相关SCI期刊导航类别中，本站只是硬性分析 "《J THORAC ONCOL》" 杂志的可信度。学术期刊真正的价值在于它是否能为科技进步及社会发展带来积极促进作用。
Witryna23 mar 2024 · JAMA Oncology—The Year in Review, 2024 Oncology JAMA Oncology JAMA Network This past year has been an exciting one for JAMA Oncology and its … WitrynaEffect of Home-Based Exercise and Weight Loss Programs on Breast Cancer-Related Lymphedema Outcomes Among Overweight Breast Cancer Survivors: The WISER …
WitrynaUnadjusted and Adjusted effect for the tumor for DFS, OS and SAR in the molecular subgroups population ... with or without cetuximab: a post hoc analysis of the PETACC-8 trial. [Published online January 14, 2016]. JAMA Oncol. doi:10.1001/jamaoncol ... Primary Tumor Location and RAS/BRAF Mutational Status as Prognostic Factor in …
WitrynaJAMA oncology publishes original research articles in the areas of Oncology and Cancer Research. The journal is targeted at academics, practitioners and scientists who are … how fast fashion exploits workersWitrynaThe budget impact of introducing avelumab was estimated to be approximately cost-neutral with a marginal increase of $719,324 (0.25% change in budget) in incremental total costs over the three-year time period ( Figure 2, Table 6 ). The incremental PMPM cost was approximately zero ($0.00) over 3 years. how fast flash can runWitrynaJCO is one of the most prestigious oncology journals in the world, with an Impact Factor of 50.717, placing it among the top 1% of all journals, and with an Eigenfactor of 0.24903, which is the highest among oncology publications. In addition, JCO has the highest h-index among oncology journals reported by Google Scholar Metrics. high efficiency submersible pond pumpWitryna24 mar 2024 · Impact factor 3.467 (2024) Five year impact factor 23 days Submission to first decision (Median) 335,089 (2024) Downloads. Latest issue. Volume 28. Issue 4, April 2024 View all volumes and issues. Latest articles. The clinical impacts of postoperative complications after colon cancer surgery for the clinical course of … high efficiency toilets for saleWitrynaJAMA Oncology is an international peer-reviewed journal and the definitive journal for scientists, clinicians, and trainees in the field of oncology. JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and … high efficiency tankless water heatersWitryna2024 Journal Metrics. On this page you will find a suite of citation-based metrics for Nature Reviews Clinical Oncology which provides an overview of this journal. Because the median is not ... how fast foods are making us a fatter countryWitryna1 gru 2024 · Humanized 3F8 Anti-GD2 Monoclonal Antibody Dosing With Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Resistant Neuroblastoma: A Phase 1 Clinical Trial ... JAMA Oncol. 2024 Dec 1;4(12):1729-1735 ... Treatment was outpatient with reversible neuropathic pain and without unexpected toxic effects. No … how fast food causes obesity